Analyst firms · Goldman Sachs · TSVT
Goldman Sachs TSVT price target and rating history
2seventy bio Inc. (TSVT) · Health Care
Goldman Sachs rates 2seventy bio Inc. (TSVT) Sell with a $2 price target, as of its latest action on Jun 6, 2024. It has published 3 rating actions on TSVT since May 2022, including 0 upgrades and 2 downgrades.
- Current rating
- Sell
- Price target
- $2
- Median target, all firms
- Too few
- Actions on TSVT
- 3
Goldman Sachs price target on TSVT
Every Goldman Sachs rating on TSVT
- Jun 6, 2024
- Sep 13, 2023
- May 2, 2022
Questions about Goldman Sachs and TSVT
- What is Goldman Sachs's price target for TSVT?
- Goldman Sachs's latest stated price target for 2seventy bio Inc. (TSVT) is $2, from its action on Jun 6, 2024.
- What is Goldman Sachs's rating on TSVT?
- Goldman Sachs rates TSVT Sell, a bearish rating, as of Jun 6, 2024.
- When did Goldman Sachs last change its view on TSVT?
- On Jun 6, 2024, Goldman Sachs downgrades to Sell from Neutral, price target $5 to $2.
More TSVT rating histories
All Goldman Sachs ratingsTSVT news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.